Protecting your valued employees.

Significant disruptions can impact companies of any size in any industry due to COVID-19 outbreaks. Implementing the right COVID-19 testing protocols can lead to:

  • Increased productivity
  • Decreased absenteeism
  • Peace of mind

We are here to help you incorporate a COVID-19 testing plan that works for your individual situation


Rapid Mobile PCR Testing For COVID-19

PCR testing for COVID-19 anytime, anywhere

SQI Diagnostics is the exclusive Canadian distributor of Biomeme’s Health Canada authorized, portable SARS-CoV-2 real-time PCR test, providing rapid, point-of-need testing in clinical, corporate and other settings. Our kits include everything you need to get from sample to result in about 90 minutes.

The test has been simplified to three steps through streamlined preparation processes that utilize pre-aliquoted and lyophilized reagents. Tests are run on the Biomeme Franklin Three9 thermocycler which is a lightweight and portable device with up to five hours of battery life, allowing for either centralized or remote testing.

This solution delivers sample to result in approximately 90 minutes with a throughput of 9 tests per one-hour thermocycler run. Results are displayed on an accompanying smart phone and can be managed through a cloud-based management system.

The Biomeme SARS-CoV-2 test detects the all the current variants of concern, including Alpha, Beta, Gamma, Epsilon, Delta and Omicron.

Key Benefits:


Gold standard test
96.9% sensitivity
98.3% specificity


Results from up to 9 samples in ~ 90 minutes


Fully portable instrument
5 hour run time on internal battery


Easy-to-use software interface to run, monitor and analyze results in real-time


3 steps: collect, prepare and process a sample


Pre-mixed and lyophilized test


Cloud-based data management; Bluetooth-enabled


Detects all WHO identified variants, including Omicron

Environmentally friendly

No cold chain shipping
Order Now

Sofia SARS Antigen Fluorescent Immunoassay (FIA)

The Sofia® SARS Antigen Fluorescent Immunoassay (FIA) by Quidel uses advanced lateral flow technology to provide accurate results for the detection of SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 analyzer, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments. The test is Health Canada-approved for symptomatic patients within the first five days of symptoms and asymptomatic patients when tested serially. It can be utilized in innovative “read now” and “walk away” modes allowing up to 50 tests run per hour per device.

The Quidel Sofia® SARS Antigen FIA detects the all the current variants of concern, including Alpha, Beta, Gamma, Epsilon, Delta and Omicron.

Key Benefits:


Objective and automated results in 15 minutes


Nasal collection with the nasal swab supplied in the kit

Extended Shelf Life

Up to 24 months

Serial Testing

Of asymptomatic populations at a minimum every 3 days/72 hours (91.6% sensitivity)

Excellent performance

Compared to molecular methods (96.7% sensitivity)*


Dual mode testing for higher throughput (up to 45 tests per hour) in a variety of environments

Integrated Data Management

Plus user and patient ID captured with onboard barcode scanner
* For patients within the first 5 days of onset of symptoms
Order Now

Sofia2 Flu+SARS Antigen Fluorescent Immunoassay (FIA)

The Sofia 2 Flu + SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from influenza A and influenza B, and SARS-CoV-2. The Sofia 2 Flu + SARS Antigen FIA with the Sofia 2 analyzer provides automated and objective results in 15 minutes, allowing for testing of patients suspected of influenza A, influenza B, and COVID-19/2019-nCoV at the Point of Care.

Order Now

The QuickVue At-Home OTC COVID-19 Test

The QuickVue At-Home OTC COVID-19 Test lets you get rapid results, in the privacy of your own home, with everything you need included in the package. It is intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 from individuals with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two to three days with at least 24 hours and no more than 36 hours between tests.

Key Benefits:

Fast and easy test

Uses a nasal swab to help detect the novel coronavirus, SARS-CoV-2, that causes COVID-19


Identified positive cases 83.5% of the time and negative cases 99.2% of the time in a clinical study


No prescription, complicated procedures or training required


Get results in 10 minutes, in the privacy of home
Order Now

EXACT COVID-19 Antibody Test

The SQI Diagnostic EXACT COVID-19 Antibody Test is the next generation of COVID-19 diagnostic tool, measuring antibody levels arising from vaccination and infection.

  • Semi-quantitative measurement of all 3 antibody isotypes – IgM, IgA, IgG of SARS-CoV-2 (COVID-19), specific for nucleocapsid and spike proteins
  • Test collection kit is shipped.
  • Simple finger-prick blood or venous blood sample
  • Results available online in 24-48 hours
  • Approved by New York State Health Department
Learn More